Every SEC Form 3/4/5 on record for this filer (CIK 1239126) — 6 issuers, 41 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| ABBV | AbbVie Inc. | Director | 2020-05-12 → 2026-05-12 | 11 | — |
| TEN | TENNECO INC | Director · lapsed | 2015-07-15 → 2022-11-21 | 12 | $453,450 |
| HNGR | HANGER, INC. | Director · lapsed | 2018-05-17 → 2022-10-04 | 6 | — |
| AGN | Allergan plc | Director · lapsed | 2018-06-15 → 2020-05-11 | 6 | $209,759 |
| HGR | HANGER, INC. | Director · lapsed | 2017-11-17 → 2017-11-17 | 2 | — |
| ABT | ABBOTT LABORATORIES | Executive Vice President · lapsed | 2016-02-23 → 2016-07-29 | 3 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
2 of 6 issuers are covered and open a security page; the rest are on file here only.